Spyre Therapeutics Inc (SYRE)

EBITDA Margin

-205.05%

TTM · Period ending:

SYRE logo

SYRE EBITDA Margin

Latest reported-205.05%
SYRE EBITDA Margin (0.00% → -205.05%)
High-resolution chart · PNG

SYRE ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
0%
-14,426.6366%
-3,520.2662%
-341.982%
0%
0%
-1,161.7798%
-526.9356%
-470.484%
-184.4864%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.